Michele Merli

45PUBLICATIONS
169CO-AUTHORS
Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Aug 31, 2026
Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

|Nov 10, 2025
Clinical Presentation, Treatment, and Outcomes of 28 Patients With Castleman Disease: A Retrospective Analysis of an Italian Cohort.

Caterina Cristinelli, Michele Merli, Marco Lucioni

|Nov 28, 2024
Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single-arm FIL-BRB trial.

Giulia Benevolo, Daniela Drandi, Nicoletta Villivà

|Jul 23, 2024
Exposure to obinutuzumab does not affect outcomes of SARS-CoV-2 infection in vaccinated patients with newly diagnosed advanced-stage follicular lymphoma.

A Pinto, M Caltagirone, M Battista

|Mar 27, 2024
Management of vaccinations in patients with non-Hodgkin lymphoma.

Michele Merli, Andrea Costantini, Silvio Tafuri

|Mar 05, 2024
Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infection.

Roberta Sciarra, Michele Merli, Caterina Cristinelli

Pageof 8

Frequent Collaborators

17 joint publications

Luca Arcaini

12 joint publications

Francesco Passamonti

7 joint publications

Marzia Varettoni

6 joint publications

Stefano Luminari